Guggenheim Downgrades Workday to Sell
Guggenheim analyst John Difucci downgrades Workday (NASDAQ:WDAY) from Neutral to Sell.
Guggenheim Downgrades Palo Alto Networks to Neutral
Guggenheim analyst John Difucci downgrades Palo Alto Networks (NASDAQ:PANW) from Buy to Neutral.
Scotiabank Downgrades ConocoPhillips to Sector Perform, Announces $140 Price Target
Scotiabank analyst Paul Cheng downgrades ConocoPhillips (NYSE:COP) from Sector Outperform to Sector Perform and announces $140 price target.
Deutsche Bank Downgrades Huntsman to Hold, Raises Price Target to $33
Deutsche Bank analyst David Begleiter downgrades Huntsman (NYSE:HUN) from Buy to Hold and raises the price target from $31 to $33.
Deutsche Bank Downgrades Eastman Chemical to Hold, Raises Price Target to $96
Deutsche Bank analyst David Begleiter downgrades Eastman Chemical (NYSE:EMN) from Buy to Hold and raises the price target from $90 to $96.
Guggenheim Downgrades Microsoft to Sell, Announces $212 Price Target
Guggenheim analyst John Difucci downgrades Microsoft (NASDAQ:MSFT) from Neutral to Sell and announces $212 price target.
Raymond James Downgrades Upland Software to Market Perform
Raymond James analyst Alexander Sklar downgrades Upland Software (NASDAQ:UPLD) from Outperform to Market Perform.
Raymond James Downgrades Texas Roadhouse to Outperform, Lowers Price Target to $110
Raymond James analyst Brian Vaccaro downgrades Texas Roadhouse (NASDAQ:TXRH) from Strong Buy to Outperform and lowers the price target from $115 to $110.
B of A Securities Downgrades First Advantage to Neutral, Announces $14.5 Price Target
B of A Securities analyst Gary Bisbee downgrades First Advantage (NASDAQ:FA) from Buy to Neutral and announces $14.5 price target.
HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.